|
36th Middle Atlantic Regional Meeting (MARM)
June 8-11 2003 Spnsored by the Trenton ACS Section and Princeton University |
|---|
| Program Id | Author Name | Author Institution | Title | Presentation Time | Building | Room |
| 12 | Paul Anderson | Independent Consultant | EVOLUTION OF MODERN DRUG DISCOVERY | Monday, Jun 9 2003 9:00AM | Jadwin | JA10 |
| 13 | Frank Koehn | Wyeth Research | RAISING THE IMPACT OF NATURAL PRODUCTS IN MODERN DRUG DISCOVERY | Monday, Jun 9 2003 9:40AM | Jadwin | JA10 |
| 14 | Edmund Graziani | Wyeth Research | NATURAL PRODUCTS CHEMISTRY AT WYETH RESEARCH: RECENT PROGRESS IN GENERATING LEADS FOR DRUG DISCOVERY | Monday, Jun 9 2003 10:00AM | Jadwin | JA10 |
| 15 | John W. Clader PH.D. | Pharmaceutical | FROM SERENDIPITY TO DESIGN: THE DISCOVERY OF EZETIMIBE AND OTHER NOVEL CHOLESTEROL ABSORPTION INHIBITORS | Monday, Jun 9 2003 10:20AM | Jadwin | JA10 |
| 16 | Thomas Edward D'Ambra | Albany Molecular Research, Inc. | SHORT HISTORY AND IMPACT OF CHEMISTRY OUTSOURCING COMPANIES ON DRUG DISCOVERY AND DEVELOPMENT. A SUPPLIERS VIEW | Monday, Jun 9 2003 11:00AM | Jadwin | JA10 |
| 17 | Robert Hormann | RHeoGene, LLC | MULTIDIMENSIONAL QSAR AND SUPERIMPOSITION EVALUATION OF ECDYSONE RECEPTOR GENE-SWITCH ACTUATORS | Monday, Jun 9 2003 11:40AM | Jadwin | JA10 |
| Program Id | Author 1 Name | Author 1 Institution | Title | Presentation Time | Building | Room |
| 73 | S. David Kimball | Lexicon Pharmaceuticals | CHALLENGES IN DRUG DISCOVERY IN THE 21ST CENTURY: TARGET VALIDATION | Monday, Jun 9 2003 2:30PM | Jadwin | JA10 |
| 74 | Timothy A. Blizzard | Merck Research Labs | 2-PHENYLSPIROINDENES AND 2-PHENYLSPIROINDENEDIONES AS NOVEL ESTROGEN RECEPTOR LIGANDS | Monday, Jun 9 2003 3:10PM | Jadwin | JA10 |
| 75 | Bart L. DeCorte | Johnson & Johnson Pharmaceutical Research & Development | DISCOVERY OF TMC125, A NEXT GENERATION NNRTI WITH ACTIVITY AGAINST SINGLE AND DOUBLE MUTANTS | Monday, Jun 9 2003 3:30PM | Jadwin | JA10 |
| 76 | Robert Aslanian | Schering-Plough Research Institute | DISCOVERY OF SCH 79687, A NOVEL IMIDAZOLE-BASED ANTAGONIST OF THE H3 RECEPTOR | Monday, Jun 9 2003 4:00PM | Jadwin | JA10 |
| 77 | Louis Lombardo | Bristol-Myers Squibb Pharmaceutical Research Institute | STUDIES DIRECTED TOWARDS THE IDENTIFICATION OF SMALL-MOLECULE INHIBITORS OF FARNESYL PROTEIN TRANSFERASE FOR ONCOLOGY INDICATIONS | Monday, Jun 9 2003 4:35PM | Jadwin | JA10 |
| 78 | Regine S Bohacek | Boston DeNovo | AlleGrow and FLO+: New Tools for Drug Design | Monday, Jun 9 2003 5:10PM | Jadwin | JA10 |